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The carboxyl terminus of the Hsc70-interacting protein
(CHIP) is an Hsp70 co-chaperone as well as an E3 ubiquitin
ligase that protects cells from proteotoxic stress. The abilities of
CHIP to interact with Hsp70 and function as a ubiquitin ligase
place CHIP at a pivotal position in the protein quality control
system,where its entrance intoHsp70-substrate complexes par-
titions nonnative proteins toward degradation. However, the
manner by which Hsp70 substrates are selected for ubiquitina-
tion by CHIP is not well understood. We discovered that CHIP
possesses an intrinsic chaperone activity that enables it to selec-
tively recognize and bind nonnative proteins. Interestingly, the
chaperone function ofCHIP is temperature-sensitive and is dra-
matically enhanced by heat stress. The ability of CHIP to recog-
nize nonnative protein structure may aid in selection of slow
folding or misfolded polypeptides for ubiquitination.
Cells must constantly monitor the folding status of nascent
polypeptides and repair or degrade misfolded proteins during
protein denaturing stress. To accomplish these tasks, the cell
relies on an intricately regulated protein quality control (QC)5
system. The cytosolic QC system consists of molecular chaper-
ones, such as Hsp70 and Hsp40, that promote the proper fold-
ing and refolding of nonnative proteins and the ubiquitin pro-
teasome system, which degrades misfolded or stress-damaged
proteins (1–4). Maintenance of cellular homeostasis requires a
delicate balance between that activity of protein folding and
ubiquitin proteasome systems. Under circumstances where the
molecular chaperone system is unable to promote proper fold-
ing of a protein substrate to its native state, it is necessary for the
substrate protein to be selected for degradation, a process that
is often referred to as protein triage (5, 6). Protein triage needs
to be tightly regulated, since the escape of toxic proteins from
QC systems or overactivity of protein degradation pathways
leads to a variety of human diseases (7).
Partitioning of nonnative polypeptides between folding and
degradation pathways appears to be influenced by the folding
kinetics of individual proteins as well as by a network of co-
chaperones that bind and regulate polypeptide binding and
release by Hsp70 family members (8–13). CHIP is a co-chaper-
one that functions as an E3 ubiquitin ligase that links the
polypeptide binding activity of Hsp70 to the ubiquitin protea-
some system. CHIP binds Hsp70 through interactions between
its N-terminal TPR domains and the C-terminal EEVD motif
found on Hsp70. The binding of CHIP to Hsp70 can stall the
folding of Hsp70 client proteins (14–16) and concomitantly
facilitate the U-box dependent ubiquitination of Hsp70-bound
substrates (16, 17). CHIP appears to play a central role in cell
stress protection (18–20) and is responsible for the degradation
of disease-related proteins that include cystic fibrosis trans-
membrane conductance regulator (15), p53 (21), huntingtin
(22), ataxin-3 (22), Tau protein (23–25), and -synuclein (26).
The domain structure of CHIP makes it uniquely suited to
adapt the polypeptide binding activity of Hsp70 for use as the
substrate selector of amultisubunit E3 ubiquitin ligase complex
that contains Hsp40 and the E2, UbcH5 (16, 27). Although the
ability of CHIP to utilize its U-box domain to attract UbcH5 to
ubiquitinate Hsp70-bound substrates is established (11, 16, 17,
27), the mechanism by which different Hsp70 clients are
selected for degradation by CHIP is not understood. This is an
important question, because productive folding intermediates
andmisfolded proteins that are bound byHsp70 appear to have
similar conformations, and it does not appear that folding
kinetics are the sole determinant of a nonnative protein’s fate
(5, 15, 28). If CHIP were able to selectively recognize nonnative
protein structure, this would help explain how Hsp70 clients
are selected for degradation.
Evidence to suggest that CHIP possesses chaperone activity
comes from experimental data in which overexpression of
CHIP or CHIPU-box in cultured cells was found to enhance
the refolding of stress-damaged proteins (18) and activate the
stress-dependent transcription factor, HSF, independent of
stress (19). In addition, a number of Hsp70 co-chaperones pos-
sess an intrinsic polypeptide binding activity and act independ-
ently to suppress protein aggregation (29–31). Based on these
observations, we tested whether CHIP could function as an
autonomous molecular chaperone. We report that CHIP
exhibits intrinsic chaperone function that enables it to bind
nonnative substrates and suppress protein aggregation. In addi-
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tion, CHIP chaperone activity was found to be enhanced by
heat stress. These data suggest that the ability of CHIP to func-
tion as a chaperone is an important feature of its action in pro-
tein triage and cell stress protection.
MATERIALS AND METHODS
Cell Culture—AD-HEK293 cells from Stratageneweremain-
tained in Dulbecco’s modified Eagle’s medium (Invitrogen)
supplemented with 10% fetal bovine serum (Hyclone) and anti-
biotics (100 units/ml penicillin and 100 g/ml streptomycin;
Invitrogen) at 37 °C in an atmosphere of 5% CO2. Cell transfec-
tionswere performedusing Effectene reagent (Qiagen)with the
indicated amounts of plasmid DNA.
Cell Culture Luciferase Assay—AD-HEK293 cells were tran-
siently transfected with 1 g of the luciferase-encoding plasmid,
pGL3 (Promega), and with 0.25 g of pCDNA3.1myc-CHIP.
Transfected cells were allowed to recover for 24 h and were then
treated with 25 g/ml cycloheximide for 30 min at 37 °C. Fol-
lowing the cycloheximide incubation, cells were either main-
tained at 37 °C or heat-stressed at 45 °C for 30 min. Recovery
periods of 0, 1, or 3 h at 37 °C were allowed, and then cells were
assayed for luciferase activity according to the manufacturer’s
protocol (Promega) or were harvested by citric saline and
lysed in an ATP-regenerating buffer consisting of 50 mM
Tris-HCl (pH 8.0), 0.5% Nonidet P-40, 120 mM NaCl, 5 mM
Mg-ATP, 40 mM creatine phosphate, and 0.25 mg/ml crea-
tine kinase for immunoprecipitation analysis. Immunopre-
cipitations were carried out by the subsequent addition of
goat -luciferase antibody (Millipore) or rabbit -Hsp70
antibody (SPA-757, Stressgen) and Protein G beads (Roche
Applied Science). Immunoprecipitated proteins were visual-
ized by Western blot.
Glutaraldehyde Cross-linking of Cell Lysates—AD-HEK293
cells transfected with pCDNA3.1myc-CHIP (0.5g) were lysed
24 h post-transfection in 50 mM Tris-HCl (pH 8.0), 0.5% Non-
idet P-40, and 120 mM NaCl. Cell lysates were incubated at 4,
37, 42, or 45 °C for 15 min, and then either water or glutaralde-
hyde (0.025% final concentration) was added to the cell lysates
(34). The cross-linking reaction was incubated for 10 min at
30 °C, and then reactions were stopped by the addition of 4
SDS-PAGE sample buffer. Samples were run on 10% gels and
blotted for the presence of CHIP with an -Myc antibody
(Sigma).
Protein Purification Procedures—The following plasmids were
used for overexpression of the indicated proteins in the BL21
E. coli strain: pET9d-Hdj2, pET11a-Hsc70 (32), pET11a-
His6UbcH5a, pET30-His6CHIPK30A, pET30-His6CHIPH260A,
pET30-His6CHIPP269A, pET11a-CHIP (16), pGST-hChip198–
303 (14), and pGex6-HD53Q (33). Hsp70, Hdj-2, andHis6-tagged
proteins were purified as previously described (32, 34, 35).
Untagged CHIP was expressed by inducing BL21 cells express-
ing pet11-CHIP with 0.1 mM isopropyl 1-thio--D-galactopy-
ranoside. Cleared lysates were obtained by sonication and cen-
trifugation at 20,000 rpm for 10 min, and then CHIP was
purified by High Q anion exchange and hydroxyapatite chro-
matography (AmershamBiosciences). All of the above proteins
were dialyzed into buffer A (150mMNaCl, 20mMK-Hepes, pH
7.4). Glutathione S-transferase (GST)-HD53Q-Myc proteins
were purified from bacteria induced with 0.1 mM isopropyl
1-thio--D-galactopyranoside by incubating the cleared
lysate with GSH beads (Sigma) for 1 h at 4 °C, which were
then washed three times with phosphate-buffered saline
(PBS) (50 mM sodium phosphate, 150 mM NaCl, pH 7.4).
Bound protein was eluted with 10 mM GSH, and samples
were dialyzed in buffer containing 50 mM Tris-HCl (pH 7.0)
and 150 mM NaCl.
Huntingtin Aggregation Assay—GST-HD53Q-Myc fusion
protein (3 M) was incubated at 30 °C with 2.5 units of PreScis-
sion protease (GEHealthcare) in Buffer B (50mMTrisHCl (pH
7.0), 150 mM NaCl, 1 mM DTT, 1 mM phenylmethylsulfonyl
fluoride, 2 mM ATP, 50 mM KCl, 5 mM MgCl2, 50 g/ml crea-
tine kinase, and 8 mM creatine phosphate) plus the indicated
proteins for 3 h. Cleavage of the GST tag allows for aggregation
and fibril formation to occur (33). Aggregation reactions were
either stopped by the addition of an equal volume of a 4% SDS,
50 mM DTT solution followed by heating at 95 °C for 5 min for
filter trap analysis or mixed with 4 native gel sample buffer
(0.24 M Tris-HCl (pH 6.8), 40% glycerol, 1% Bromphenol Blue)
and run on a 7% native gel. Filter trap analysis was carried out
with cellulose acetate filters (0.2-mpore size) using a Bio-Rad
Slot Blot apparatus. HD-53Q-Myc protein was visualized by
performing a Western blot using an -Myc antibody (Sigma).
Luciferase Native Gel Assay—To examine the state of dena-
tured luciferase, the luciferase was incubated in denaturation
buffer (25 mM K-Hepes (pH 7.4), 50 mM KCl, 5 mM MgCl2, 6 M
guanidinium HCl (GdmHCl), 5 mM DTT) for 1 h at 25 °C. The
denatured luciferase was then diluted into refolding buffer (25
mM K-Hepes (pH 7.4), 50 mM KCl, 5 mM MgCl2, 1 mM ATP)
with the indicatedmixture of proteins and incubated for 20min
at 25 °C before the addition of 4 native sample buffer (0.24 M
Tris-HCl (pH 6.8), 40% glycerol, 1% bromphenol blue) and
application to a 7% native polyacrylamide gel.
In Vitro Oligomerization Assay—Proteins were diluted in
Buffer A (150 mM NaCl, 20 mM K-Hepes (pH 7.4)) to a final
concentration of 0.3 mg/ml. Samples were then incubated at
either 4 or 42 °C for 15 min. 4 native sample buffer (0.24 M
Tris-HCl (pH 6.8), 40% glycerol, 1% bromphenol blue) was
added to each sample, and they were then applied to 7% native
polyacrylamide gels, whichwere prepared according to the Lae-
mmli method without SDS. The running buffer consisted of 50
mM Tris and 384 mM glycine. Gels were run for 3.5 h at a con-
stant current of 15 mA.
Luciferase Aggregation Assay—Luciferase was diluted to a
final concentration of 100 nM in reactions containing the indi-
cated proteins in 120 mM NaCl, 40 mM K-Hepes (pH 7.4), 50
mM KCl, 5 mM MgCl2, 1 mM ATP, and 1 mM DTT. Aliquots of
each reaction were stored on ice to represent total protein lev-
els. Samples were incubated at room temperature for 5 min,
followed by a 15-min incubation at 4 °C for native luciferase and
a 15-min incubation at 42 °C for heat-denatured luciferase.
Samples were centrifuged at 20,000 rpm (Beckman Allegra 64R
centrifuge; 4 °C), after which the supernatants were separated
from the pellet. Pellets were resuspended in a volume of 4%
SDS, 350mM -mercaptoethanol, representing 5 times the vol-
ume that was originally centrifuged. The total aliquots and
supernatants were also diluted 1:5 in 4% SDS, 350 mM -mer-
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captoethanol. All fractions were heated at 55 °C for 10 min and
then were applied to a nitrocellulose membrane using a Bio-
Rad slot blot apparatus.Western blots were performed using an
-luciferase antibody (Cortex).
Luciferase Holding and Refolding Assay—Refolding of chem-
ically denatured firefly luciferase (Promega) was carried out as
described previously (35). Briefly, luciferase (14.2 mg/ml) was
diluted 42-fold into denaturation buffer (25 mM K-Hepes (pH
7.4), 50 mM KCl, 5 mMMgCl2, 6 M guanidiniumHCl, and 5 mM
dithiothreitol). The denaturation reaction was allowed to pro-
ceed for 1 h at 25 °C, and then a 1-l aliquot was removed and
mixedwith 125l of refolding buffer (25mMK-Hepes (pH 7.4),
50 mM KCl, 5 mM MgCl2, 1 mM ATP) that was supplemented
with the indicated chaperone proteins and incubated at 25 °C.
Where indicated, after 90 min, the reaction was split into two,
and 1.5 M Ssa1 and 5.5 M Ydj1 was added to one half of the
reaction, whereas Buffer A was added to the other half. The
reactions were then incubated for another 30 min at 25 °C. Ali-
quots of 1 l were removed from the folding reactions and
mixed with 60 l of luciferase assay reagent (Promega). Lucif-
erase activity was then measured with a Turner TD-20/20
Luminometer.
Enzyme-linked Immunosorbent Assay (ELISA) to Measure
Polypeptide Binding byHsp70—Apreviously established ELISA
was used tomeasure complex formation betweenHsp70 proteins
and denatured luciferase (36). Hsp70 was diluted into PBS. Then
100-l aliquots of 50 nM Hsp70 solutions were added to the
wells of microtiter plates. The Hsp70 was allowed to adhere to
the walls of wells during a 1-h incubation at 25 °C. Wells were
washed to remove unbound Hsp70 with 50 mM phosphate, pH
7.4, 150 mM NaCl, 0.02% Triton X-100 (PBST). Wells were
blocked via a 1-h incubation with 200 l of 1% bovine serum
albumin in PBS. GdmHCl-denatured luciferase (0.4 g) was
diluted into reactions containing the indicated amounts of
CHIP in PBSwith 0.02%TritonX-100, 0.2% bovine serumalbu-
min, and 1 mM ATP and then added to each well. After a 1-h
incubation at 25 °C, the wells were washed three times with
PBST. Luciferase retained in the wells was detected with a
1:5000 dilution of rabbit -luciferase (Cortex Biochem, San
Leandro, CA) in PBST. -Luciferase was incubated in the wells
for 1 h at 25 °C, and then following three washes with PBST,
goat -rabbit serum coupled with horseradish peroxidase was
used to detect the luciferase antibody retained in the wells.
Three more washes with PBST were performed to wash away
any unbound secondary antibody. Hydrogen peroxide (0.05%
final concentration) was added to a solution containing 0.22
mg/ml 2,2-azinobis-(3-ethylbenzothiazoline-6-sulfonate) in
50 mM sodium citrate, pH 4.0. This 2,2-azinobis-(3-ethylben-
zothiazoline-6-sulfonate) solution was added to the wells of the
microtiter plate, and color formation was measured at 405 nm
with a microplate reader (Bio-Rad).
Rhodanese Aggregation Assay—Rhodanese aggregation was
determined using light scattering as previously described (37).
In brief, bovine rhodanese (50M; Sigma)was denatured for 1 h
at 25 °C in 6 M guanidine HCl buffered with 10 mM Tris-HCl,
pH 7.4, and 10 mM DTT. Upon denaturation, rhodanese was
diluted 100-fold into 400l of reaction buffer containing 10mM
Tris-HCl, pH 7.4, 25 mM KCl, and 10 mM DTT. If included,
chaperones were added to the reaction mixture prior to the
addition of denatured rhodanese. In order to prepare the heat-
shocked CHIP, an aliquot of CHIP was placed at 42 °C for 15
min and set on ice for 3 min before being diluted 10-fold into
the reaction mixture. The rate of rhodanese aggregation was
determined by observing the increase in light scattering in the
sample over time using a spectrophotometer set at 320 nm.
Ubiquitination Assays —Ubiquitination assays were per-
formed in a reaction buffer composed of 20 mM K-Hepes (pH
7.4), 50 mM NaCl, 5 mM MgCl2, 4 mM ATP, 2 mM DTT, 0.5
mg/ml bovine ubiquitin (Sigma), 0.01mg/ml rabbit E1 (Calbio-
chem), 8 M UbcH5a, and 4 M CHIP unless otherwise indi-
cated. Additional proteins were added at the indicated concen-
trations. Incubations were performed at 37 °C for 3 h and
terminated by the addition of 4 SDS sample buffer. Proteins
were resolved on 10% SDS-polyacrylamide gels, transferred to
nitrocellulose membranes, and detected by blotting with the
indicated antibodies.
RESULTS
Characterization of CHIP Activity during Heat Stress and
Recovery—To expand our knowledge of CHIP action in protein
triage, we sought to understand the enigmatic observation that
overexpression of CHIP in cultured cells enhances refolding of
heat-denatured luciferase (18). This result was puzzling,
because purified CHIP functions with Hsp70 to polyubiquiti-
nate misfolded luciferase (38) and therefore CHIP would be
expected to clear denatured luciferase from the cell instead of
enhancing its reactivation.
To determine the mechanism by which CHIP influences
denatured luciferase activity, HEK-AD 293 cells were trans-
fected with luciferase and CHIP expression plasmids. Then
luciferase activity as well as complex formation between CHIP
and luciferase were analyzed following heat denaturation. Heat
stress reduced luciferase activity by almost 80% in control cells,
and luciferase activity was partially recovered during a post-
stress recovery incubation at 37 °C. Consistent with an earlier
report (18), luciferase activity was consistently higher in cells
overexpressing CHIP (Fig. 1A). However, the effect of CHIP on
luciferase activity following heat stress was somewhat variable,
because when identical experiments were carried out with high
passage number cells (i.e. passage 50 versus passage 15), lucif-
erase activity immediately following heat shock was decreased
in response to CHIP overexpression (data not shown). How-
ever, in all cases, the rate at which luciferase activity was
restored after heat stress was enhanced by CHIP overexpres-
sion. Western blots indicated that differences in luciferase
activity observedwere not due to the presence of different levels
of total luciferase protein in different cell extracts (Fig. 1B).
Thus, the presence of abnormally high levels of CHIP, which
are likely to exceed the levels of its cognate E2 ubiquitin-conju-
gating enzyme, UbcH5, helps maintain a pool of denatured
luciferase in a folding-competent and reactivable state.
Hsp70 and CHIP were both shown by co-immunoprecipita-
tion to bind heat-stressed luciferase (Fig. 1B). Interestingly, the
number of Hsp70-luciferase complexes that were isolated
increased a few-fold in the presence of excess CHIP (Fig. 1B).
The association of CHIP with luciferase appeared to be confor-
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mationally specific, because it was found to associatewith inactive
luciferase inheat-treatedcells butnot in controlswhere itwas fully
active (Fig. 1B). Indeed, as the luciferase refoldedduring the recov-
ery period, the amount of CHIP isolated in a complex with lucif-
erase decreased in a manner that was proportional to increases in
luciferase activity.
Hsp70-dependent and -independent Effects of CHIP onDena-
tured Substrates—Whether the interactions between luciferase
andCHIP are due to a direct binding of luciferase to CHIP or an
effect of CHIP on Hsp70 binding to luciferase is difficult to
evaluate in cultured cells. Therefore, we set out to determine if
purified CHIP could function as a chaperone and bind nonna-
tive polypeptides independent of Hsp70. Luciferase was chem-
ically denaturedwithGdmHCl and then diluted into a refolding
buffer containing CHIP, Hsp40, Hsp70, or different combina-
tions thereof. Native gels were utilized to detect the amount of
luciferase that formed a complex with the different chaperone
proteins and therefore could enter the native gel matrix (Fig.
2A). In the absence of chaperones, negligible quantities of dena-
tured luciferase entered the native gel matrix (Fig. 2A), which
makes it difficult to quantitate the absolute percentage of lucif-
erase that is bound by chaperone proteins. However, in com-
parison with the negative control (luciferase diluted into
buffer), CHIP was able to bind and shift 38% (average value
from three independent experiments) more luciferase into the
gel, which is impressivewhen considering that the combination
FIGURE 1. A, overexpression of CHIP protects luciferase activity after heat
stress. A, AD-HEK 293 cells (passage 15) were transfected with 1 g of the
firefly luciferase-encoding plasmid, pGL3, with and without Myc-CHIP (0.25
g). The cells were treated with cycloheximide (25 g/ml) 24 h after transfec-
tion for 30 min at 37 °C to inhibit synthesis of new luciferase protein. The cells
were then maintained at 37 °C or switched to 45 °C for 30 min and were
harvested after a 0-, 1-, or 3-h recovery period at 37 °C. Cells were lysed in 1
reporter lysis buffer (Promega) and assayed for luciferase activity following
the protocol provided by Promega. Results represent the average from three
independent experiments and are plotted relative to the control activity with-
out heat treatment. p values were calculated by Microsoft Excel using a one-way
analysis of variance analysis comparing those cells that were and were not over-
expressing CHIP (*, p  0.036; **, p  0.002; ***, p  0.019). B, overexpression of
CHIP does not result in an increased degradation of heat-denatured lucifer-
ase, but CHIP does specifically interact with heat-denatured luciferase and
not refolded luciferase. Cells were transfected with the indicated plasmids at
the same concentrations as used in A and then lysed in 4 sample buffer for
whole cell lysates or in an ATP-regenerating buffer for immunoprecipitations
(I.P.) with either luciferase antibody (Millipore) or Hsp70 antibody (Stressgen).
Products of the immunoprecipitations were run on a 10% SDS-polyacrylam-
ide gel and analyzed by Western blot with Myc, Hsp70, or luciferase
antibodies.
FIGURE 2. CHIP enhances interactions between Hsp70 and substrate. In
A, luciferase was denatured in 6 M GdmHCl and then diluted into reactions
containing the indicated proteins (0.615 M Hsp40, 0.615 M Hsp70, 2.5 M
CHIP). After a 20-min incubation at 25 °C, samples were mixed with 4 native
sample buffer and loaded on a 7% native gel. Proteins were then transferred
to nitrocellulose and probed using an -luciferase antibody. A representative
blot is shown, but quantitation indicated below represents the average from
three independent experiments. B, ELISA to quantitate luciferase binding to
Hsp70. The wells of a microtiter plate were coated with 5 pmol of Hsp70,
washed, and blocked as described under “Materials and Methods.” Luciferase
was denatured in 6 M GdmHCl and then diluted into reactions containing no
CHIP or 10 pmol of CHIP. These mixtures were then added to the microtiter
wells, and the amount of luciferase that bound Hsp70 was determined as
described under “Materials and Methods.” Values represented are the aver-
age of three independent samples, and a p value of 0.0008 (*) was calculated
for the difference between samples with and without CHIP using a one-way
analysis of variance calculation in Microsoft Excel. C and D, GST-HD-53Q-Myc
was incubated in cleavage buffer containing Precision Protease in the pres-
ence of the indicated proteins for 3 h at 30 °C (1.5 M Hsp40, 3 M Hsp70, 6 M
CHIP). The cleavage of the GST tag allowed for aggregation and fibril forma-
tion of the HD-53Q-Myc. The sample was split into two, and in C was mixed
with 4 native gel sample buffer and run on a 7% native gel. Proteins were
then transferred to nitrocellulose and visualized by Western blot with an
-Myc antibody. D, the other half of the sample from C was analyzed by filter-
ing through a 0.2-m pore size cellulose acetate membrane, and then protein
aggregates that were large enough to be retained by the cellulose acetate
were visualized by performing a Western blot with -Myc antibody. Quanti-
tations were performed using the Quantity One software from Bio-Rad.
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of Hsp40 andHsp70 together led to a 25% increase in luciferase
migration into the gel (average value from three independent
experiments). These results indicate that CHIP is able to bind a
denatured substrate independent of interactions with Hsp70.
However, the most dramatic gel shift results were observed
in the presence of Hsp40, Hsp70, and CHIP together. The com-
bination of all three chaperones resulted in a 100% increase in
the amount of luciferase migrating into the native gel matrix
(average value from three independent experiments). This
value surpasses that of a simple additive effect from the three
proteins and suggests that Hsp40 and CHIP act jointly to
enhance complex formation between Hsp70 and denatured
luciferase. The apparent cooperative action ofHsp40 andCHIP
in enhancing substrate binding by Hsp70 is consistent with the
observation that the joint presence of purified CHIP, Hsp40,
and Hsp70 is required for efficient E2-dependent polyubiquiti-
nation of luciferase (38).
In order to obtain more of a quantitative view of the effect of
CHIP on Hsp70 substrate complexes, we utilized a modified
ELISA assay tomonitor luciferase binding toHsp70 (36).Hsp70
was bound to the wells of a 96-well plate, and luciferase was
added in the presence or absence of CHIP. The presence of
CHIP resulted in a 73% increase in the amount of luciferase,
which was found in complex with Hsp70 (Fig. 2B), which fur-
ther supports the interpretation that CHIP can enhance the
formation of Hsp70-substrate complexes. Together, the native
gel shift results alongwith the ELISA results are consistent with
the notion that CHIP is a chaperone and suggest that it can
function via twomechanisms tomodulate the fate of denatured
luciferase. 1) CHIP can directly bind denatured substrates, and
2) CHIP can act in concert with Hsp70 to maintain denatured
substrates in a soluble state.
To ascertain whether the ability of CHIP to act in concert
with Hsp70 to maintain substrates in a soluble state is specific
to luciferase or potentially a general mechanism of action, we
examined this effect with another Hsp70 substrate, HD-53Q,
which represents exon 1 of Huntingtin protein with an
expanded polyglutamine region (33). Previously, Hsp70 was
shown to suppress HD-53Q aggregation (33), and overexpres-
sion of CHIP has been shown to protect cells from polyglu-
tamine aggregation in a U-box-independent fashion (39). The
ability of CHIP and Hsp70 to maintain HD-53Q in a soluble
statewas determinedwith native gels and cellulose acetate filter
trap assays (33). Native gel analysis demonstrates that HD
aggregates do not readily enter the gel matrix, whereas soluble
HD-53Q migrates into gels (Fig. 2C, lane 1). The inability of
HD-53Q aggregates to enter native gels makes it difficult to
quantitate the total extent to which chaperones suppress
HD-53Q aggregation. Nevertheless, we can use this method to
compare the relative ability of different chaperones to suppress
HD-53Q aggregation and preserve the soluble state. The pres-
ence of Hsp70maintains a portion of HD-53Q in a soluble state
(lanes 3 and 5), but the addition of CHIP in combination with
either Hsp40/Hsp70 or Hsp70 alone results in a much greater
quantity of the HD-53Q protein entering the native gel matrix
(Fig. 2C, lanes 6 and 8). These same samples were also analyzed
by a cellulose acetate filter trap assay in order to detect large
protein aggregates (33). The filter trap assay shows that
althoughHsp40 andHsp70 are able to inhibit aggregate forma-
tion, this effect is greatly enhanced by the presence of CHIP
(Fig. 2D, lanes 5 and 6). In these experiments, Hsp70 was pres-
ent at levels where it was ineffective at independently suppress-
ing the formation of large HD53Q aggregates. Thus, it is clear
that CHIP can cooperate with Hsp70 to suppress HD-53Q
aggregation. However, CHIP did not appear to independently
bind HD-53Q and inhibit its aggregation (Fig. 2, C (lane 4) and
D (lane 4)). The combination of the native gel and filter trap
assays allows for visualization of soluble protein and of protein
aggregates larger than 0.2 m, but it must be noted that there
may be smaller aggregates formed that are not detected by
either assay. Regardless, the data in Fig. 2 show thatCHIP is able
to independently maintain denatured luciferase in a soluble
state (Fig. 2A, lanes 2 and 6). However, CHIP appears to influ-
ence the dynamics of HD-53Q aggregation by enhancing the
ability of Hsp70 to suppress the formation of large aggregates.
Luciferase is a typical globular protein that contains a num-
ber of hydrophobic motifs that are recognized by chaperones,
which helps explain why CHIP can readily suppress its aggre-
gation (40–42). HD-53Q is an atypical protein that is encoded
by a version of exon 1 from the Huntingtin protein that is com-
posed primarily of Gln residues and thereforemay not be a high
affinity substrate for CHIP (43). CHIP being inefficient at sup-
pressing HD53Q aggregation yet still enhancing Hsp70 action
in suppressing HD 53Q aggregation is consistent with the
notion stated above that binding of CHIP to Hsp70 enhances
Hsp70-polypeptide formation.
Suppression of LuciferaseAggregation by PurifiedCHIP—The
native gel shift analysis demonstrated that CHIP can function
as a chaperone to bind chemically denatured luciferase inde-
pendent of Hsp70. Since CHIP was shown to protect luciferase
from thermal denaturation in the context of the cellular milieu,
the ability of CHIP to suppress the aggregation of thermally
denatured luciferase was tested (Fig. 3). Heating luciferase to
42 °C causes it to denature and form an insoluble aggregate that
will pellet upon high speed centrifugation (44). When CHIP
was present during the denaturation step, it acted in a con-
centration-dependent manner to maintain heat-denatured
luciferase in a soluble state and prevented the formation of pel-
letable luciferase aggregates (Fig. 3). These data further support
the interpretation that CHIP possesses intrinsic chaperone
activity and raise the question as to whether or not this chaper-
one activity is responsible for U-box-independent functions of
CHIP (19, 18, 39).
To explore the subdomains of CHIP that are responsible for
its chaperone function, the ability of purified point mutants in
both its TPR (CHIP K30A) and U-box (CHIP H260A) domains
was determined. Mutation of the TPR motif abrogated the in
vitro chaperone activity, whereas the CHIP U-box mutant was
still fully active (Fig. 3). In an extension of these studies,
CHIPTPR (CHIP-(198–303)) was found to be unable to sup-
press luciferase aggregation, and surprisingly CHIPU-box
(CHIP-(1–197)) was also inactive. Both the TPR and the
U-box proteins have previously been shown to fold correctly
such that CHIPTPR can function to bind E2 enzymes (45) and
CHIPU-box can bind chaperones (6). However, neither of
these CHIP truncation proteins were active in aggregation
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assayswhen present individually or in combination (Fig. 3). The
study of CHIP point mutants suggests that the polypeptide
binding activity resides in its TPR domain. However, fragments
of CHIP that lack either of these domains are not functional as
chaperones. Since the overexpression ofCHIPU-box protects
cultured cells from proteotoxicity (18), the inability of
CHIPU-box to suppress protein aggregation was a surprise.
However, since CHIPU-box can still bind Hsp70, it may exert
its cytoprotective effects by modulating substrate binding to
Hsp70. Overall, these data suggest that the TPR domains play
an important role in the function of CHIP as a molecular
chaperone.
Heat-dependent Enhancement of CHIP Chaperone Activity—
Many chaperones exhibit increased chaperone activity upon
exposure to heat stress (HS) (46–48). Therefore, upon demon-
stration of a chaperone activity for CHIP, the effect of heat
treatment onCHIPwas also determined.Chemically denatured
luciferase was used in aggregation assays to directly compare
the chaperone activity of CHIP incubated at 25 or 42 °C for 15
min (HS CHIP). We found that heat treatment greatly
enhanced the ability of CHIP to function as a chaperone and
prevent aggregation of the chemically denatured luciferase (Fig.
4A). We also noted a slight difference between the ability of HS
CHIP to suppress aggregation of heat-denatured versus chem-
ically denatured luciferase (compare Fig. 3 (row 5) and Fig. 4A
(row 3)). The HS CHIP was more efficient at suppressing the
aggregation of the heat-denatured substrate, potentially due to
the fact that CHIP is present during the denaturation stage and
may be able to trap intermediates before the luciferase com-
pletely unfolds.
Co-immunoprecipitation experiments demonstrate that
when chemically denatured luciferase is diluted into buffer
containing either CHIP or HS CHIP, a significant level of lucif-
erase binding above background is observed for both condi-
tions. However, heat treatment increases complex formation
between CHIP and chemically denatured luciferase 3-fold
(Fig. 4B).
Since heat treatment enhances the ability of CHIP to bind
luciferase, we set out to determine if heat treatment would also
enhance the ability of CHIP to inhibit polyglutamine aggrega-
tion. Previously, CHIP was observed to only inhibit HD-53Q
aggregation in the presence of Hsp70 and not on its own (Fig. 2,
C and D), yet heat treatment of CHIP enhanced its concentra-
tion-dependent ability to suppress aggregation ofHD-53Q (Fig.
4C). Furthermore, HS CHIP functioned in a manner similar to
the Hsp40, Ydj1, in the suppression of chemically denatured
rhodanese (37) (Fig. 4D), whereas a similar concentration of
CHIP was less active than HS CHIP in suppressing rhodanese
aggregation. Thus, we have demonstrated with three different
substrates that heat treatment enhances the ability of CHIP to
suppress protein aggregation.
Effect of Heat Treatment on CHIP Oligomeric Status and
Function—Heat stress-induced enhancement of the polypep-
tide binding activity of a specific chaperone has been correlated
with changes in the oligomeric state of the chaperone protein
(46–49). Therefore, the oligomeric state of CHIP in extracts
from control (37 °C) and heat-treated (42 and 45 °C) cells was
probed with the aid of glutaraldehyde cross-linking and SDS-
PAGE (Fig. 5A). Cells expressing Myc-CHIP were lysed, the
extractswere split in half, and 0.025%glutaraldehydewas added
to one aliquot and water to the other. Upon analyzing both
cross-linked and noncross-linked samples on SDS-polyacryl-
amide gels, it was observed that regardless of heat treatment,
when the cell lysateswere not cross-linkedwith glutaraldehyde,
the CHIP migrated at the expected molecular mass of a CHIP
monomer (36 kDa). In cell lysates that were not heat-shocked,
the glutaraldehyde cross-linking resulted in a shift in the CHIP
molecular weight to that of a dimer, as expected from previous
reports (50, 51). However, after a heat shock of cells at 42 or
45 °C, CHIP was shown to form a high molecular weight com-
plex, which upon cross-linking migrates at the top of the gel. In
fact, after the 45 °C incubation, both the monomer and dimer
forms of CHIP disappeared from the cross-linked sample,
although the same decrease in total CHIP protein is not
observed in the control. This suggests that the 45 °C heat shock
causes CHIP to enter a large complex that cannot migrate into
the gel. These large complexes observed after heat shock may
represent a change in the homo-oligomeric status of CHIP, and
this change in state may account for its increased ability to
suppress protein aggregation. However, it is also possible that
FIGURE 3. CHIP acts as a chaperone to prevent aggregation of thermally
denatured luciferase. Luciferase was added to solutions containing the indi-
cated proteins, and solutions were then incubated at room temperature for 5
min. During this incubation period, aliquots were taken to represent the total
amount of luciferase present in each mixture. Native luciferase samples were
then incubated on ice, whereas other samples were heat-denatured at 42 °C
for 15 min. All mixtures were centrifuged at 20,000 rpm for 10 min in a Beck-
man Allegra 64R centrifuge, and the supernatants were separated from the
pellets. Total (T), supernatant (S), and pellet (P) fractions were diluted in 4%
SDS with 350 mM -mercaptoethanol and applied to nitrocellulose using a
Bio-Rad slot blot apparatus. Luciferase was visualized by blotting with -lu-
ciferase antibody (Cortex).
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heat shockmay drive the entrance of CHIP into largemultipro-
tein complexes that contain other cellular proteins and dena-
tured proteins.
In order to directly determine whether CHIP undergoes
heat-induced oligomerization, we analyzed the affect of heat
stress on purified CHIP proteins by native gel electrophoresis
(Fig. 5B). Heat treatment at 42 °C for 15 min caused both wild
type CHIP and CHIP H260A, a U-box mutant, to form high
molecular weight oligomers, whereas the CHIP TPR mutant,
CHIPK30A, CHIPTPR(CHIP-(198–303)), and CHIPU-box
(CHIP-(1–197)) proteins remained at the same molecular
weight as observed in controls (Fig. 5B). Thus, forms of CHIP
that do not act to suppress protein aggregation in a heat-de-
pendentmanner also fail to oligomerize after heat stress (Figs. 3
and 5B). The ability of CHIP to oligomerize correlates well with
the temperature-sensitive enhancement of its chaperone
activity.
Since heat treatment causes a conformational change in
CHIP that results in oligomerization, we sought to verify that
heat stress does not affect the global conformation of CHIP in
such away to disrupt itsHsp70 binding or ubiquitin ligase activ-
ity. The functionality of heat-treated CHIP was tested using
polyubiquitination assays, since wild-type CHIP proteins pro-
mote the E2-dependent formation
of polyubiquitin chains whenmixed
with ubiquitin, ATP, E1, and the E2,
UbcH5a (17). Heat treatment does
not diminish the ability of CHIP,
CHIP K30A, or CHIP-(198–303) to
stimulate UbcH5a to assemble
polyubiquitin chains (Fig. 5C).
CHIP P269A was expected to be
inactive, because it has a defective
U-box and does not stimulate the
ability of UbcH5 to form polyubiq-
uitin chains (52). HS CHIP is also
able to polyubiquitinate Hsp70 in a
manner similar to CHIP (Fig. 5D),
indicating that HS CHIP is not
denatured, since it retains its ubiq-
uitination activity as well as its abil-
ity to interact with Hsp70. Overall,
these data show that heat stress
induces a conformational change in
CHIP that enhances the intrinsic
chaperone activity of the protein
but does not affect other CHIP
activities.
CHIP Maintains Substrates in a
Ubiquitination-competent State—
CHIP has the ability to maintain
substrates in a soluble state both
through an interaction with Hsp70
and through an intrinsic chaperone
activity. Therefore, we set out to
determine how this activity is
related to its function in protein tri-
age. To establish whether the ability
of CHIP to maintain denatured substrates in a soluble fashion
affects the ability of those substrates to be ubiquitinated, both
“holding” and “folding” assays (35) were performed in parallel
with ubiquitination assays (Fig. 6). CHIP and HS CHIP exhib-
ited negligible ability to refold GdmHCl-denatured luciferase
(Fig. 6A).However, CHIP functioned in a temperature-depend-
ent manner to maintain or hold denatured luciferase in a fold-
ing-competent state (Fig. 6B).When luciferase was diluted into
buffer alone and incubated for 90 min, it aggregated and there-
fore could not be refolded upon the addition of Hsp40 and
Hsp70. Strikingly, when denatured luciferase was diluted into
mixtures containing CHIP, which was preincubated at a variety
of temperatures, CHIP maintained the luciferase in a foldable
state over the 90-min primary incubation, because a significant
portion of luciferase could be refolded upon the addition of
Hsp40 and Hsp70. CHIP, which was preincubated at 37 °C had
approximately half the holding activity of the Hsp40 folding
factor, Ydj1 (35, 37), whereas the holding activity of CHIP pre-
incubated at 42 °C matched that of Ydj1.
Since CHIP is able tomaintain heat-denatured luciferase in a
foldable form, by analogy we hypothesized that this chaperone
activity should hold luciferase in a ubiquitination-competent
conformation. To test this, the ability of luciferase to be ubiq-
FIGURE 4. Heat treatment enhances the chaperone activity of CHIP. A, luciferase was chemically denatured
using 6 M GdmHCl (dluc) and then diluted into reactions containing Buffer A alone or an 8 M solution of
proteins that were either preincubated at 4 °C (CHIP) or at 42 °C (HS CHIP) and then cooled on ice. Luciferase
samples were then incubated at 25 °C for 20 min, fractionated into total (T), supernatant (S), and pellet (P)
fractions, and visualized by Western blot with -luciferase antibody (Cortex). B, heat treatment increases the
affinity of CHIP for denatured luciferase. Reactions were prepared as in A, except after the 20-min incubation at
25 °C, 1 l of luciferase antibody (Ab) was added to samples where indicated, and complexes were then
isolated with Protein G-agarose beads. The samples lacking luciferase antibody serve as a negative control for
background binding of proteins to Protein G-agarose beads. C, HD-53Q aggregation is inhibited by heat-
treated CHIP. GST-HD53Q-Myc (1.5 M) was incubated in cleavage buffer containing the indicated concen-
trations of CHIP protein, which was preincubated at either 4 °C (CHIP) or 42 °C (HS CHIP) for 15 min.
Precision Protease was then added to the cleavage reactions, and they were incubated for 3 h at 30 °C and
stopped by the addition of a 4% SDS, 50 mM DTT solution. Samples were applied to a 0.2-m cellulose
acetate filter using a Bio-Rad slot blot apparatus, and HD53Q aggregates were visualized by Western blot
with -Myc antibody. D, rhodanese was denatured in 6 M GdmHCl for 1 h and then diluted into buffer with
and without chaperones. Aggregation kinetics were measured by light scattering at a wavelength of 320
nm. I.P., immunoprecipitation; WB, Western blot.
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uitinated after heat denaturation in the presence or absence of
CHIP was investigated. After heat denaturation of luciferase
ubiquitin, ATP, E1, and the E2, UbcH5a, were added to the
luciferase reactions. In addition, non-heat-treated CHIP was
included in samples that did not containCHIP during the initial
denaturation step. When CHIP was present during the initial
heat denaturation step instead of added afterward, an increased
level of luciferase ubiquitination was observed (Fig. 6C). HS
does not appear to enhance the E3 activity of CHIP, because
CHIP and HS CHIP stimulate the ability of UbcH5a to catalyze
polyubiquitin chain assembly or ubiquitinate Hsp70 to the
same degree (Fig. 5, C and D).
The ability of CHIP to suppress protein aggregation is suffi-
cient to maintain luciferase in a soluble conformation that can
be acted upon by chaperones or ubiquitin-conjugating
enzymes. However, it is noteworthy to point out that the lucif-
erase ubiquitination reactions shown were carried out in the
absence of Hsp40 orHsp70. Thus, in instances where CHIP can
bind a nonnative substrate independent of Hsp70, it can also
cooperate with UbcH5a to ubiquitinate those substrates inde-
pendent of Hsp70. The extent to which CHIP functions inde-
pendently of Hsp70 in cells to facilitate protein ubiquitination
requires further study, but there may be instances where this
occurs.
DISCUSSION
Data presented are the first to classify CHIP as an E3 ligase
that functions autonomously as a temperature-sensitivemolec-
ular chaperone. CHIP was found to selectively bind nonnative
proteins and maintain them in a soluble state that could subse-
quently be ubiquitinated by the E2 UbcH5. Thus, the ability of
CHIP to recognize nonnative structure is an additional feature
of its role in protein triage, and we envision scenarios in which
CHIP would utilize its chaperone activity in both Hsp70-de-
pendent and -independent processes. The integrated chaper-
one, co-chaperone, and ubiquitin ligase activities of CHIP may
play a role in selection of slow folding or misfolded Hsp70 cli-
ents for ubiquitination and proteasomal degradation. CHIP
also has the potential to utilize its intrinsic polypeptide binding
activity to act independently of Hsp70 to select nonnative sub-
strates for ubiquitination. This latter scenario helps to explain
how direct binding of CHIP to Smad1 regulates the half-life of
Smad1 (53, 54).
The mechanistic details of how interactions between CHIP
and Hsp70 regulate the Hsp70 polypeptide binding and release
cycle are not clear and are open to alternate interpretations (4,
FIGURE 5. Characterization of heat-treated CHIP. A, AD HEK293 cells were
transfected with pCDNA Myc-CHIP (0.5 g) and 24 h post-transfection were
lysed in buffer containing 50 mM Tris-HCl (pH 8.0), 0.5% Nonidet P-40, and 120
mM NaCl. Lysates were then treated at either 4, 37, 42, or 45 °C for 15 min. After
this incubation, glutaraldehyde was added to the cell lysates at a final con-
centration of 0.025%, and samples were incubated for 10 min at 30 °C. The
cross-linking reaction was stopped by the addition of sample buffer, the sam-
ples were run on a 10% SDS-polyacrylamide gel, and CHIP was visualized by
Western blot with an -Myc antibody (Sigma). B, native polyacrylamide gels
were used in order to determine the oligomeric status of CHIP proteins before
and after heat treatment in vitro. CHIP was diluted in Buffer A to a concentra-
tion of 0.3 mg/ml and incubated at 4 or 42 °C for 15 min. Samples were then
mixed with 4 native sample buffer and applied to a 7% polyacrylamide
native gel, and proteins were visualized by Coomassie Brilliant Blue stain.
C, CHIP proteins are still functional after heat treatment. CHIP proteins (8 M)
were preincubated at the indicated temperature for 15 min and then cooled
on ice for 5 min. CHIP samples were then diluted 2-fold into ubiquitination
reactions containing a final concentration of 20 mM K-Hepes (pH 7.4), 50 mM
NaCl, 5 mM MgCl2, 4 mM ATP, 2 mM DTT, 0.5 mg/ml bovine ubiquitin (Sigma),
0.01 mg/ml rabbit E1 (Calbiochem), and 8 M UbcH5a. Ubiquitination reac-
tions were incubated for 3 h at 37 °C before the addition of 4 sample buffer.
Proteins were run on 10% gels and transferred to nitrocellulose for visualiza-
tion by Western blot with an -ubiquitin antibody. D, CHIP and HS CHIP both
interact with and ubiquitinate Hsp70. CHIP (25 M) was preincubated at
either 4 or 42 °C and then diluted to a final concentration of 4 M in ubiquiti-
nation reactions containing the above components plus 1 M Hsp70 and 2 M
Hdj-2 (Hsp40). Ubiquitination reactions were incubated for 3 h at 37 °C before
the addition of 4 sample buffer. Proteins were run on 10% gels and trans-
ferred to nitrocellulose for visualization by Western blot with an -Hsp70
antibody (SPA-757; Stressgen).
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18). We interpret our data to suggest that the coupled TPR-de-
pendent binding of CHIP to Hsp70 and nonnative proteins
serves to stabilize Hsp70-polypeptide complexes and thereby
drive the assembly of the CHIP E3 ubiquitin ligase complex.
The ability of CHIP to enhance Hsp70-polypeptide complex
formation is supported by the following observations. 1) In the
presence of overexpressed CHIP, an increase in the quantity of
immunoprecipitable Hsp70-substrate complexes was detected
(Fig. 1) (18), and 2) the addition of purified CHIP to mixtures
that contained Hsp70 and denatured polypeptide led to an
increase in Hsp70-polypeptide complex formation, as demon-
strated by the native gel analysis and ELISA (Fig. 2). This CHIP
action appeared to be due to an effect of CHIP on the stability of
preformed Hsp70-substrate complexes, because native CHIP
was not able to independently suppress HD-53Q aggregation
but enhanced the ability of Hsp70 to suppress aggregation sev-
eralfold. Finally, the proposed action of CHIP in stabilizing
Hsp70-polypeptide complexes is consistent with the ability of
CHIP to reduce Hsp40-stimulated Hsp70 ATPase activity (14).
The ADP form of Hsp70 has a high affinity for substrates, and if
CHIP were to stabilize Hsp70-polypeptide complexes, this
would slow the regeneration of theATP form ofHsp70. Amore
detailed study of interaction between Hsp70, CHIP, and model
substrates is required to prove the above interpretations of our
data.
SinceCHIP chaperone functions are enhanced by heat stress,
CHIP may also have added roles during times of cellular stress.
In fact, the enhanced ability of heat stressed CHIP to interact
with denatured substrates may aid in its ability to protect cells
and whole organisms from heat stress (18–20). In addition to
interacting with Hsp70 to clear stress-damaged protein from
cells, it is possible that CHIP utilizes its chaperone functions to
interact with proteins such as HSF to regulate cell stress
response (19, 20).
The mechanism by which heat enhances CHIP chaperone
function is not clear. It is likely that the temperature-dependent
oligomerization of CHIP and the formation of a multivalent
chaperone account for its enhanced polypeptide binding activ-
ity. However, it is also possible that heat drives a conforma-
tional change that increases the exposure of its polypeptide
binding site. Nevertheless, numerous other chaperones, such as
the small HSPs, have been demonstrated to respond to their
cellular environment with a change in oligomeric status and a
corresponding change in chaperone activity (49, 55–59). The
observations of CHIP change in oligomeric status and corre-
sponding enhanced chaperone activity fit well with observa-
tions that indicate that CHIP is a dynamic protein that assumes
more than one distinct conformation (45, 51). When mouse
CHIPwas co-crystallized with a C-terminal Hsp90 peptide that
contained an EEVDmotif, CHIP was found to exist as an asym-
metric dimer (45). In contrast, the crystallization of a zebrafish
CHIP construct that was missing the TPR domains but con-
FIGURE 6. CHIP maintains denatured luciferase in a folding- and ubiquiti-
nation-competent state. A, CHIP does not refold denatured luciferase to a
native state. Luciferase refolding assays were performed as described under
“Materials and Methods.” Briefly, luciferase was denatured in 6 M GdmHCl and
then diluted into samples containing CHIP proteins that had been preincu-
bated at the indicated temperatures. The folding reactions were then incu-
bated for 90 min at 25 °C, and the luciferase activity was measured on a Turner
luminometer. The graph represents the average values obtained from two
independent experiments. B, luciferase was denatured in 6 M GdmHCl and
then diluted into reactions containing the indicated proteins. After a 25 °C,
90-min incubation, the sample was split in half such that either buffer A or a
mixture of Ssa1/Ydj1 (final concentrations of 1.5 and 5.5 M, respectively) was
added to each half. The buffer served as a negative control, whereas Ssa1 and
Ydj1 are chaperones that will readily fold any luciferase that still remains in a
folding-competent conformation. Samples were further incubated for 30
min, at which time luciferase activity was measured on a luminometer. The
activity from the luciferase sample that received the buffer for refolding was
considered background and was subtracted from the activity measured in
the presence of Ssa1 and Ydj1. The graph represents the average of two inde-
pendent experiments, and error bars represent the S.D. C, if CHIP is present
during the heat denaturation of luciferase, it can maintain the luciferase in a
ubiquitination-competent state. Luciferase was first diluted into reactions
containing either buffer A or 2 M CHIP, and aliquots were taken in order to
show the amount of luciferase in the starting material. Luciferase reactions
were then subjected to thermal denaturation by incubating at 42 °C for 15
min and then diluted into a secondary ubiquitin reaction mixture and incu-
bated at 37 °C for 3 h (postubiquitination). All secondary reaction mixtures
contained 20 mM K-Hepes (pH 7.4), 50 mM NaCl, 5 mM MgCl2, 4 mM ATP, 2 mM
DTT, 0.5 mg/ml bovine ubiquitin (Sigma), and, where indicated, the E1 (0.01
mg/ml rabbit E1 (Calbiochem)) and E2 (8 mM UbcH5a) ubiquitination
enzymes. If CHIP was present during the initial heat denaturation step, then
no additional CHIP was added to the secondary reaction mixture, but if CHIP
was absent from the first reaction, then it was added to the secondary reac-
tion at an equivalent final concentration (1 M). Reactions were stopped by
the addition of 4 SDS sample buffer, the samples were run on a 10% gel, and
the proteins were transferred to nitrocellulose. Luciferase was visualized by
Western blot with an -luciferase antibody (Cortex).
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tained the helical linker andU-box domains revealed a symmet-
ric dimer (51). The differences in CHIP structure might be due
to the fact that the zebrafish CHIP was crystallized in the
absence of the TPR domains. However, it is also possible that
the TPR domains of CHIP are not only required for binding to
Hsp70 but may also serve to regulate or facilitate other aspects
of CHIP activity.
Indeed, data presented demonstrate that CHIP TPRmutants
do not exhibit the same degree of conformational plasticity as
CHIP. A single point mutation in the TPR domain, K30A, or
deletion of the TPR of CHIP prevents heat-induced oligomer-
ization of CHIP and blocks its chaperone activity. These data
suggest that either a particular conformation of the TPR
domain is necessary for the protein to adopt the chaperone
active state or that the TPR domain itself is where the polypep-
tide binding activity is localized. TheCHIP polypeptide binding
site remains to be identified, but the crystal structure of CHIP
solved byZhang et al. (45) has identified solvent exposedhydro-
phobic patches on the surface of the TPR domain that have the
potential to interact with nonnative polypeptides (41).
In light of our data about the lack of chaperone activity of the
CHIP TPR mutants, those who study CHIP need to be careful
when interpreting experiments in which TPR mutants are uti-
lized. This is the case because CHIP TPRmutants are unable to
interact with Hsp70 and are used as a control to demonstrate
that a specific activity is attributable to the interaction of CHIP
with Hsp70. However, since CHIP is a chaperone and since its
chaperone function is dependent upon the TPR domain, new
controls will need to be carried out to assure that CHIP is acting
through Hsp70 to modulate the activity of specific substrates.
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